LUT-014
- Generic Name
- LUT-014
A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform Lesions
- First Posted Date
- 2019-03-15
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- Lutris Pharma Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT03876106
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸UCLA Health Santa Monica - Cancer Care, Los Angeles, California, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath